Key Details About Lantheus' Upcoming Earnings Call
As the financial landscape of the radiopharmaceutical sector continuously evolves, Lantheus Holdings, Inc. is set to lead the conversation. The company will be hosting an informative conference call and webcast to discuss its financial results and provide updates for the third quarter of 2025. This event is scheduled for 8:00 a.m. ET on November 6, 2025.
How to Participate in the Earnings Call
For those looking to gain insights into Lantheus' performance and strategic direction, participation in the earnings call is encouraged. Interested individuals can easily register online ahead of the event. To ensure a smooth experience, it's advisable to sign up at least fifteen minutes before the call begins. This will allow ample time to address any potential technical issues and ensure you are ready to access the valuable information that will be shared.
The Importance of Timely Registration
Timely registration helps avoid delays and ensures that all participants can access the live event without interruption. Details of the registration link can be found on Lantheus' investor relations website, where additional information will also be made available.
Replay Availability for Investors
After the conclusion of the earnings call, Lantheus plans to provide a replay of the webcast approximately two hours later. This archived session will remain accessible on the company’s website for at least thirty days, allowing stakeholders and interested parties to revisit the crucial updates shared during the call.
About Lantheus Holdings, Inc.
Lantheus is recognized as a leader in the radiopharmaceutical field, dedicated to delivering transformative solutions that empower healthcare providers to diagnose and manage diseases effectively. With nearly seventy years of commitment to innovation, the company has made significant strides in improving patient outcomes.
Global Presence and Commitment to Healthcare
Headquartered in Massachusetts, Lantheus operates internationally, with offices in multiple countries including Canada, Germany, Sweden, Switzerland, and the United Kingdom. This extensive reach underscores their commitment to enhancing global health through pioneering radiopharmaceutical technologies.
Contacts for Investor Relations
For inquiries regarding investor relations, stakeholders can reach out to:
Mark Kinarney
Vice President, Investor Relations
Phone: 978-671-8842
Email: ir@lantheus.com
For media inquiries, you can contact:
Melissa Downs
Executive Director, External Communications
Phone: 646-975-2533
Email: media@lantheus.com
Frequently Asked Questions
What is the date and time of the Lantheus Q3 2025 earnings call?
The Lantheus Q3 2025 earnings call is scheduled for November 6, 2025, at 8:00 a.m. Eastern Time.
How can I access the earnings call?
Participants can register online to access the earnings call. It is recommended to do this at least fifteen minutes prior to the event.
Will there be a replay of the earnings call?
Yes, a replay will be available approximately two hours after the call ends and will be archived on Lantheus' investor relations website for at least thirty days.
What type of company is Lantheus?
Lantheus is a leading company in the radiopharmaceutical sector, focusing on innovative solutions for disease diagnosis and management.
Where is Lantheus headquartered?
Lantheus is headquartered in Massachusetts, with additional offices in various countries worldwide.
